EKR Therapeutics - Ownership and Business Overview

Life ScienceCompany

EKR Therapeutics Ownership

Who owns EKR Therapeutics?

EKR Therapeutics is owned by Cornerstone Therapeutics. It was acquired on June 27, 2012.

Was EKR Therapeutics formerly PE-backed?

Yes. EKR Therapeutics was formerly owned by 2 private investors.

EKR Therapeutics Business Overview

Where is EKR Therapeutics headquartered?

EKR Therapeutics is headquartered in Bedminster, New Jersey.

What sector is EKR Therapeutics in?

EKR Therapeutics is a life science company.

When was EKR Therapeutics founded?

EKR Therapeutics was founded in 2005.

Life Science M&A Summary in 2012

Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.

Join Mergr to view all 125 acquisitions of life science companies in 2012, including 18 acquisitions by private equity firms, and 107 by strategics.

EKR Therapeutics, Inc.

1545 US Highway 206, 3rd Floor,
Bedminster, New Jersey 07921
United States,
(877) 435-2524
www.ekrtx.com

EKR Therapeutics, Inc. is a specialty pharmaceutical company providing novel products that offer broad therapeutic potential and superior outcomes to acute-care hospitals.


 Subscribe to unlock this and 206,067
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 201K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 79K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.